News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
Presentation TCT 2020 TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR) Presenter: Hashrul Rashid October 14, 2020
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
Presentation TCT 2019 PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves Presenter: Raj Makkar September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
Presentation TCT 2019 Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance Presenter: Lars Sondergaard September 26, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Daily News TCT 2018 High Mortality but Durable Results With Valve-in-Valve TAVR Michael O'Riordan September 23, 2018
Presentation TCT 2018 Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker September 23, 2018
Presentation TCT 2018 Case #4: Clinically Significant TAVR Leaflet Thrombosis Presenter: Samir R. Kapadia, Bernard Prendergast, Eric Eeckhout, Ganesh Manoharan, John C. Messenger, Bernhard Reimers, Paul Sorajja, Eric Vang September 23, 2018
Presentation TCT 2018 Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas September 22, 2018
Presentation TCT 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno September 22, 2018
Presentation TCT 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard September 22, 2018
Presentation TCT 2018 To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum September 22, 2018
Presentation TCT 2018 To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla September 22, 2018
Presentation TCT 2018 How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke September 22, 2018
Presentation TCT 2018 Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb September 22, 2018
News Conference News TCT 2017 Early Pilot Study Results Show Symptom Improvement With TMVR Michael O'Riordan November 07, 2017
Presentation TCT 2016 Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights Presenter: Raj Makkar, Lars Sondergaard October 31, 2016
Presentation TCT 2016 TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation Presenter: John M. Lasala, Philippe Pibarot, Jürgen Rothe October 31, 2016